Effects of Pomegranate Extract Supplementation (Punica granatum L.) on Clinical Manifestations of Pulmonary Arterial Hypertension in Children with Acyanotic Congenital Heart Disease

Audylia Hartono, - and Mahrus A. Rahman, - and Budi Utomo, - (2022) Effects of Pomegranate Extract Supplementation (Punica granatum L.) on Clinical Manifestations of Pulmonary Arterial Hypertension in Children with Acyanotic Congenital Heart Disease. Pharmacognosy Journal, 14 (6s). pp. 1061-1066. ISSN 09753575

[img] Text (Similarity)
4 Similarity.pdf

Download (1MB)
[img] Text (Artikel)
Artikel 4.pdf

Download (408kB)
[img] Text (Bukti Etik)
4 Bukti Etik.pdf

Download (146kB)
[img] Text (Bukti Korespondensi)
4 Bukti Korespondensi.pdf

Download (462kB)
[img] Text (Karil)
FORM KARIL 4.pdf

Download (273kB)
Official URL: https://www.phcogj.com/article/1949

Abstract

Background: Pulmonary arterial hypertension (PAH) in congenital heart disease (CHD) mechanism includes vasoconstriction and vascular remodeling. In Indonesia, sildenafil as a vasodilator is the only standard treatment for PAH. Research on pomegranate extract showed its potential as an anti-inflammatory and anti-proliferative agent that could work synergically with sildenafil in reducing pulmonary arterial pressure (PAP) Objective: To investigate the effect of pomegranate supplementation in the clinical manifestation of PAH in children with acyanotic CHD. Methods: This study was a randomized controlled clinical trial that compared the clinical manifestation of PAH in children with acyanotic CHD who received standard therapy for PAH and pomegranate extract supplementation with the placebo group. Observations were carried out over three months, and pre-and post-test evaluations were conducted to assess changes in PAP, functional classification of PAH, body weight, systolic blood pressure, heart rate, respiratory rate, and oxygen saturation in both groups. Statistical analysis was undertaken using the Wilcoxon, Mann-Whitney, and Spearman correlation tests. Results: There was no significant difference in PAP reduction between the pomegranate and placebo groups (p = .44) and no significant difference in the functional classification of PAH in the placebo and pomegranate groups (p = .55). There was a considerable reduction in the respiratory rate in the pomegranate group (p = .017). Respiratory rate was positively correlated with the functional classification of PAH (p = .011). Conclusion: There was a significant reduction in the respiratory rate in the pomegranate group that correlated with the functional classification of PAH.

Item Type: Article
Uncontrolled Keywords: Heart disease, Pomegranate, Pulmonary hypertension, Sildenafil
Subjects: R Medicine > R Medicine (General)
R Medicine > RJ Pediatrics
Divisions: 01. Fakultas Kedokteran > Ilmu Kesehatan Anak (Sub Spesialis)
Creators:
CreatorsNIM
Audylia Hartono, -UNSPECIFIED
Mahrus A. Rahman, -NIDN8819020016
Budi Utomo, -NIDN0018055904
Depositing User: arys fk
Date Deposited: 21 Jun 2023 08:10
Last Modified: 21 Jun 2023 08:10
URI: http://repository.unair.ac.id/id/eprint/127460
Sosial Share:

Actions (login required)

View Item View Item